• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Senator Tommy Tuberville's Latest 2 Stock Trades Attract The Wrong Kind Of Attention: 'Should This Be Allowed?'

    3/19/24 2:17:07 PM ET
    $HUMA
    $INTC
    $SBLK
    $SSBK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Semiconductors
    Technology
    Get the next $HUMA alert in real time by email

    The trading activity of stocks and options by members of Congress continues to be highly scrutinized as potential conflicts of interest are highlighted.

    A prominent senator recently disclosed several stock transactions, which are drawing attention on social media.

    What Happened: No stranger to stock and options trading, Senator Tommy Tuberville (R-Ala.) recently disclosed several transactions made on Feb. 27.

    The Senator disclosed buying $50,000 to $100,000 in shares of regional bank Southern States Bancshares (NASDAQ:SSBK), which has locations in Alabama and Georgia.

    "Alabama Senator Tuberville reported buying stock in Alabama bank Southern States $SSBK on Friday afternoon. Also, the CEO of $SSBK Steve Whatley has donated thousands of dollars to ‘TUBERVILLE FOR SENATE.' Should this be allowed?" CongressTrading shared on X, formerly known as Twitter.

    The bank has a market capitalization of $216 million, making this one of the smaller stocks traded by a member of Congress in 2024.

    Tuberville also disclosed buying $50,000 to $100,000 in shares of Star Bulk Carriers Corp (NASDAQ:SBLK), which caught the attention of Quiver Quant, which tracks Congress trading activity.

    "Just found something wild. Senator Tommy Tuberville just bought up to $100K of stock in a company called Star Bulk Carriers. Star Bulk Carriers specializes in shipping forestry products. Tuberville sits on the Senate Committee on Forestry," Quiver Quant tweeted.

    Quiver Quant said that Tuberville also sits on the Senate Committee on Commodities.

    "Note that $SBLK ships a variety of products, including iron ore, minerals and grain."

    Related Link: 10 Best Stock Traders In Congress In 2023 (Spoiler: Nancy Pelosi Has Reentered The Chat)

    Why It's Important: Potential conflicts of interest in trades of stocks and options have previously been highlighted regarding Tuberville, particularly given his committee assignments.

    Tuberville bought call options and put options on United States Steel Corporation (NYSE:X). With his appointment to the Senate Commodity Subcommittee, Tuberville is involved in overseeing the steel industry.

    United States Steel is subject to a takeover attempt by Japanese company Nippon Steel, which has drawn backlash from members of Congress and President Joe Biden. With an active trading position, Tuberville could be influenced in deciding whether Congress should block or approve the buyout.

    Tuberville buying shares of small-cap biotech company Humacyte Inc (NASDAQ:HUMA) drew red flags from investors. The company has been working with Ukraine on humanitarian efforts. Tuberville's position on the Senate Armed Services Committee could present a conflict of interest with the trade. The senator recently bought more Humacyte shares.

    The senator also purchased shares of Intel Corporation (NASDAQ:INTC) several days before the CHIPS Act was signed into law by President Biden. The CHIPS Act gave $50 billion in funding to microchip companies, including Intel.

    “You voted for Senator Tuberville to represent you, instead he's trading cattle, wheat and corn contracts. Btw he sits on the Senate Agriculture Committee,” CongressTrading tweeted in September 2021.

    A previous report from the New York Times highlighted Tuberville buying or selling stock and options in 17 companies that had business in front of Senate committees on which he served.

    Representatives for Tuberville told the Montgomery Advertiser previously that he has financial advisors who manage his portfolio.

    While some members of Congress have supported a ban on stock and options trading, Tuberville has opposed such a measure in the past, calling it "ridiculous."

    "I think it would really cut back on the amount of people that would want to come up here and serve, I really do. We don't need that," Tuberville told The Independent in 2022.

    Read Next: Pelosi Loves Palo Alto Networks Stock, So Do These Other Top Performing Traders In Congress

    Image created using artificial intelligence with Midjourney.

    Get the next $HUMA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HUMA
    $INTC
    $SBLK
    $SSBK

    CompanyDatePrice TargetRatingAnalyst
    Intel Corporation
    $INTC
    2/13/2026$45.00Neutral
    DA Davidson
    Intel Corporation
    $INTC
    1/20/2026$50.00Reduce → Hold
    HSBC Securities
    Intel Corporation
    $INTC
    1/20/2026$65.00Neutral → Buy
    Seaport Research Partners
    Intel Corporation
    $INTC
    1/15/2026$50.00Sector Perform
    RBC Capital Mkts
    Intel Corporation
    $INTC
    1/15/2026$50.00Sell → Neutral
    Citigroup
    Intel Corporation
    $INTC
    1/13/2026$60.00Sector Weight → Overweight
    KeyBanc Capital Markets
    Intel Corporation
    $INTC
    1/5/2026$50.00Hold → Buy
    Melius
    Intel Corporation
    $INTC
    11/21/2025Mkt Perform
    Raymond James
    More analyst ratings

    $HUMA
    $INTC
    $SBLK
    $SSBK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    DA Davidson initiated coverage on Intel with a new price target

    DA Davidson initiated coverage of Intel with a rating of Neutral and set a new price target of $45.00

    2/13/26 8:31:53 AM ET
    $INTC
    Semiconductors
    Technology

    Intel upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded Intel from Reduce to Hold and set a new price target of $50.00

    1/20/26 8:43:57 AM ET
    $INTC
    Semiconductors
    Technology

    Intel upgraded by Seaport Research Partners with a new price target

    Seaport Research Partners upgraded Intel from Neutral to Buy and set a new price target of $65.00

    1/20/26 8:19:33 AM ET
    $INTC
    Semiconductors
    Technology

    $HUMA
    $INTC
    $SBLK
    $SSBK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 4 filed by Zagari Raffaele

    4/A - Star Bulk Carriers Corp. (0001386716) (Issuer)

    4/1/26 3:46:48 PM ET
    $SBLK
    Marine Transportation
    Consumer Discretionary

    SEC Form 4 filed by Zagari Raffaele

    4 - Star Bulk Carriers Corp. (0001386716) (Issuer)

    4/1/26 12:28:06 PM ET
    $SBLK
    Marine Transportation
    Consumer Discretionary

    Amendment: SEC Form 3 filed by new insider Zagari Raffaele

    3/A - Star Bulk Carriers Corp. (0001386716) (Issuer)

    4/1/26 12:24:56 PM ET
    $SBLK
    Marine Transportation
    Consumer Discretionary

    $HUMA
    $INTC
    $SBLK
    $SSBK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Intel Appoints Aparna Bawa as Executive Vice President and Chief Legal & People Officer

    Intel Corporation today announced the appointment of Aparna Bawa as EVP, chief legal & people officer. Bawa will report directly to CEO Lip-Bu Tan and will lead Intel's global legal, ethics, compliance, people, and culture organizations as the company accelerates its transformation and execution agenda. "The role of legal and people leadership has never been more critical as Intel drives cultural transformation with discipline, speed, and integrity," said Intel CEO Lip-Bu Tan. "Aparna brings a rare combination of operational rigor, business judgment, and people-first leadership. Her experience helping scale global technology companies through periods of significant change will be invaluab

    4/2/26 4:05:00 PM ET
    $INTC
    Semiconductors
    Technology

    Intel to Repurchase 49% Equity Interest in Ireland Fab Joint Venture

    Intel Corporation (NASDAQ:INTC) and Apollo (NYSE:APO) today announced a definitive agreement for Intel to repurchase the 49% equity interest in the joint venture related to Intel's Fab 34 in Ireland not held by Intel for $14.2 billion. The agreement reflects Intel's continued business momentum underpinned by the growing and essential role CPUs play in the era of AI, a significantly strengthened balance sheet and the strong partnership between Intel and Apollo. In 2024, Apollo-managed funds and affiliates led an $11.2 billion investment to acquire a 49% equity interest in a joint venture entity related to Fab 34, providing Intel with equity-like capital while preserving balance sheet stren

    4/1/26 9:00:00 AM ET
    $APO
    $INTC
    Investment Managers
    Finance
    Semiconductors
    Technology

    Intel to Report First-Quarter 2026 Financial Results

    Intel Corporation today announced that it will report first-quarter financial results on Thursday, April 23, 2026, promptly after close of market. Intel will then hold an earnings conference call at 2 p.m. PT that day to discuss the results. A live public webcast of the earnings conference call can be accessed on Intel's Investor Relations website at intc.com. Associated materials and webcast replay will also be available on the site. About Intel Intel (NASDAQ:INTC) designs and manufactures advanced semiconductors that connect and power the modern world. Every day, our engineers create new technologies that enhance and shape the future of computing to enable new possibilities for ever

    3/31/26 5:02:00 PM ET
    $INTC
    Semiconductors
    Technology

    $HUMA
    $INTC
    $SBLK
    $SSBK
    SEC Filings

    View All

    Intel Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - INTEL CORP (0000050863) (Filer)

    4/3/26 12:50:37 PM ET
    $INTC
    Semiconductors
    Technology

    SEC Form 10-K filed by Humacyte Inc.

    10-K - Humacyte, Inc. (0001818382) (Filer)

    3/27/26 4:45:33 PM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SCHEDULE 13D/A filed by Humacyte Inc.

    SCHEDULE 13D/A - Humacyte, Inc. (0001818382) (Subject)

    3/24/26 6:02:32 AM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $HUMA
    $INTC
    $SBLK
    $SSBK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CFO Zinsner David bought $249,985 worth of shares (5,882 units at $42.50), increasing direct ownership by 2% to 247,392 units (SEC Form 4)

    4 - INTEL CORP (0000050863) (Issuer)

    1/27/26 4:28:29 PM ET
    $INTC
    Semiconductors
    Technology

    Chief Commercial Officer Scheessele William John bought $9,999 worth of shares (6,493 units at $1.54), increasing direct ownership by 42% to 22,018 units (SEC Form 4)

    4 - Humacyte, Inc. (0001818382) (Issuer)

    4/15/25 4:03:35 PM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CFO and Chief Corp. Deve. Off. Sander Dale A. bought $30,600 worth of shares (20,000 units at $1.53) (SEC Form 4)

    4 - Humacyte, Inc. (0001818382) (Issuer)

    4/14/25 9:00:23 AM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $HUMA
    $INTC
    $SBLK
    $SSBK
    Financials

    Live finance-specific insights

    View All

    Intel to Report First-Quarter 2026 Financial Results

    Intel Corporation today announced that it will report first-quarter financial results on Thursday, April 23, 2026, promptly after close of market. Intel will then hold an earnings conference call at 2 p.m. PT that day to discuss the results. A live public webcast of the earnings conference call can be accessed on Intel's Investor Relations website at intc.com. Associated materials and webcast replay will also be available on the site. About Intel Intel (NASDAQ:INTC) designs and manufactures advanced semiconductors that connect and power the modern world. Every day, our engineers create new technologies that enhance and shape the future of computing to enable new possibilities for ever

    3/31/26 5:02:00 PM ET
    $INTC
    Semiconductors
    Technology

    Humacyte To Announce 2025 Fourth Quarter and Year End Financial Results and Provide Business Update on March 27, 2026

    DURHAM, N.C., March 23, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that the Company will release its financial results for the quarter and year ended December 31, 2025 on Friday March 27, 2026. Management will host a webcast and conference call at 8:00 a.m. Eastern Time to provide a corporate and financial update. TitleHumacyte 2025 Fourth Quarter and Year End Financial Results and Corporate UpdateDateMarch 27, 2026Time8:00 a.m. Eastern TimeConference Details1-877-704-4453 (U.S. Investors)1-201-389-0920 (International Investors)1

    3/23/26 8:00:00 AM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Star Bulk to Acquire 16 Vessels from Diana Shipping Inc. Conditional Upon the Success of Its Offer to Acquire Genco Shipping & Trading Ltd

    ATHENS, Greece, March 06, 2026 (GLOBE NEWSWIRE) -- Star Bulk Carriers Corp. (the "Company" or "Star Bulk") (NASDAQ:SBLK), today announced it has entered into a conditional Sale and Purchase Agreement (the "SPA") to acquire sixteen vessels from Diana Shipping Inc. (("Diana", NYSE:DSX), subject to Diana successfully acquiring all issued and outstanding shares of Genco Shipping & Trading Ltd. (("Genco", NYSE:GNK), not already owned by Diana. The aggregate purchase price for the sixteen-vessel acquisition is $470.5 million in cash ("Purchase Price"). The SPA is subject to (i) an agreement being entered between Diana and Genco and successfully being consummated and (ii) customary conditions to

    3/6/26 9:29:37 AM ET
    $DSX
    $GNK
    $SBLK
    Marine Transportation
    Consumer Discretionary

    $HUMA
    $INTC
    $SBLK
    $SSBK
    Leadership Updates

    Live Leadership Updates

    View All

    Intel Appoints Aparna Bawa as Executive Vice President and Chief Legal & People Officer

    Intel Corporation today announced the appointment of Aparna Bawa as EVP, chief legal & people officer. Bawa will report directly to CEO Lip-Bu Tan and will lead Intel's global legal, ethics, compliance, people, and culture organizations as the company accelerates its transformation and execution agenda. "The role of legal and people leadership has never been more critical as Intel drives cultural transformation with discipline, speed, and integrity," said Intel CEO Lip-Bu Tan. "Aparna brings a rare combination of operational rigor, business judgment, and people-first leadership. Her experience helping scale global technology companies through periods of significant change will be invaluab

    4/2/26 4:05:00 PM ET
    $INTC
    Semiconductors
    Technology

    Humacyte Appoints Rick McElheny as Senior Vice President of Business Development

    - Mr. McElheney brings more than 15 of years' experience in corporate development and alliance management at biopharma companies. -  - He will work with the Company's leadership team to expand corporate collaborations to accelerate the development and commercialization of Humacyte's broad pipeline - DURHAM, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it has appointed Rick McElheny to the role of Senior Vice President of Business Development. Mr. McElheny will work with the Company's leadership team to expan

    3/26/26 8:00:00 AM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Intel Appoints Dr. Craig H. Barratt to Board of Directors

    Intel Corporation (NASDAQ:INTC) today announced that Craig H. Barratt, Ph.D., 63, has been appointed to its board of directors, effective immediately. Dr. Barratt will serve as an independent director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251110908011/en/Dr. Craig H. Barratt joins Intel's board as an independent director. "Craig is a highly accomplished technology leader with a proven ability to innovate, scale, and transform businesses," said Lip-Bu Tan, Intel CEO. "He is a seasoned semiconductor executive with experience at multiple leading-edge technology companies, which will be invaluable as we continue to execute

    11/10/25 6:21:00 PM ET
    $ALAB
    $INTC
    $ISRG
    Semiconductors
    Technology
    Industrial Specialties
    Health Care

    $HUMA
    $INTC
    $SBLK
    $SSBK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Humacyte Inc.

    SC 13D/A - Humacyte, Inc. (0001818382) (Subject)

    11/20/24 7:10:08 PM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Humacyte Inc.

    SC 13D/A - Humacyte, Inc. (0001818382) (Subject)

    11/18/24 4:10:14 PM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by United States Steel Corporation

    SC 13G - UNITED STATES STEEL CORP (0001163302) (Subject)

    11/14/24 4:05:43 PM ET
    $X
    Steel/Iron Ore
    Industrials